Resources
Filter by Topic
- Publication
Authors: Matthew Sussman, Jennifer Benner, Peter Neumann, Joseph Menzin Published: Cephalalgia, 2018. Click here for the full article.
- Publication
Authors: M Sussman, A O’Sullivan, A Shah, J Menzin, M Olfson Published: Value in Health, ISPOR 2018 Click here for the article.
- Publication
Authors: Iris Lin, Ruslan Horblyuk, Jack Mardekian, Sang Hee Park, Shital Kamble, Melissa Hamilton, Younos Abdulsattar, William Petkun, Joseph Menzin, and Gregory Y Lip Published: Circulation,...
- Publication
Authors: N Edwards, M Munsell, J Menzin, A Phillips Published: Patient Related Outcome Measures, 2018 Click here to view.
- Publication
Authors: Michael Munsell, Molly Frean, Joseph Menzin, and Amy L. Phillips Published: BMC Neurology Click here for the article.
- Publication
Authors: Tracy Li, PhD; Neal Shore, MD; Maneesha Mehra, PhD; Mary Todd, MD; Ryan Saadi, MD; Gaetan Leblay, MBA; Jyoti Aggarwal, MHS; Robert Griffiths, MS,...
- Publication
Authors: M Zilberberg, G Schneider, and H Patel Published: SHEA Spring 2017 Conference Click here for the article.
BHE is Now Panalgo: Why We Changed Our Name and Brand
In 1996, I started Boston Health Economics (BHE) to provide professional research services to the life sciences industry, including economic modeling, database analyses and strategic
BHE Announces Rebrand to Panalgo, Continues Its Mission of Leadership in Analytics Software for Healthcare [Press Release]
BOSTON, Mass. – July 27, 2020 – BHE, a leading healthcare analytics company, is now Panalgo. The new name reflects the company’s commitment to expanding the accessibility
The Pressure To Publish Rapidly: The Risks Vs. Rewards Of Fast-Tracked COVID-19 Studies
In this article with Health IT Outcomes, Joseph Menzin discusses fast-tracked COVID-19 studies, noting that with the fear surrounding the pandemic and the pressure to both
BHE Announces Formation of Strategic Advisory Board
BHE, a leading healthcare analytics company, has announced the formation of its Strategic Advisory Board. The initial appointments include Peter Neumann, ScD, Director of the
Pandemic Pricing: The Risks and Rewards of Fast-Tracking Value-Based Drug Evaluations
Matt Sussman, VP of Modeling & Strategy at Panalgo, discusses the risks and rewards of fast-tracking drug price evaluations in the COVID era in this
Value-Based Contracting for Pharma: Coordinating Data and Analytics Ownership with Payers and Providers
Click here to read the article.
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization